Idera Pharma

Related by string. * : Idera TLR7 8 . concerning Idera Pharmaceuticals . Idera Pharmaceuticals develops . Idera Pharmaceuticals Inc. . Idera Pharmaceuticals . Idera disclaims any . Idera Quarterly Report . Idera Pharmaceuticals Announces / pharmas . Pharmas . pharma . PHARMA : pharma ceutical . Sun Pharma . pharma biotech . Omega Pharma Lotto . Elder Pharma . Omega Pharma . Royalty Pharma * *

Related by context. Frequent words. (Click for all words.) 66 Emisphere Technologies 63 DRRX 63 Cyclacel Pharmaceuticals 63 FY# Guidance 63 Meets Primary Endpoint 62 Clinical Trial Results 62 Guides FY# Quick Facts 61 ONTY 61 Receives Orphan Drug Designation 61 CRXX 61 Arch Neurol 61 Guides Q4 60 DVAX 60 Forecast Quick Facts 60 Provides Shareholder 60 Clinical Trials Update 60 Ardea Biosciences 60 THERAPEUTICS 60 Drug Candidate 59 BPAX 59 J Pediatr 59 Phase Ib II 59 Obstet Gynecol 59 Am J Obstet 59 NBIX 58 #.#/Share [002] 58 Somaxon Pharmaceuticals 58 DETECTS BEARISH ENGULFING PATTERN 58 AMD# [002] 58 VICL 58 Callisto Pharmaceuticals 58 Initiate Phase 58 Phase III Clinical Trial 58 Sunesis Pharmaceuticals 58 Stock Profiler.US 58 Idenix Pharmaceuticals 58 Director Shareholding 58 Genelabs Technologies Inc. 57 Lexicon Pharmaceuticals 57 Sinobiopharma Inc. 57 Lubiprostone 57 Senesco Technologies 57 BPZ Resources 57 Pivotal Phase III 57 ENZN 57 DETECTS BEARISH HARAMI PATTERN 57 Am J Epidemiol 57 Pulmonary Arterial Hypertension 57 SMARTREND DETECTS CONTINUED SELLING 57 J Clin Endocrinol Metab 57 RELEASES ITS QUARTERLY NUMBERS 57 Presidio Pharmaceuticals 57 Annual Meeting Date 57 Abstract Number 56 SCLN 56 Candente Resource Corp. 56 Phase III Trial 56 II Clinical Trial 56 THRX 56 RPRX 56 QGEN 56 Ambrisentan 56 J Am Acad 56 Gemini Explorations Inc. 56 Am J Clin 56 Chronic Hepatitis C 56 SMARTREND RESEARCH REPORT AVAILABLE 56 Completes Enrollment 56 Nasdaq REGN 56 Guanilib 56 Poster Presentation 55 www.labopharm.com 55 3rd Quarter Results 55 Diabetic Neuropathy 55 Phase Ib clinical 55 Owens Corning OC 55 SearchGold Resources Inc. 55 TSX AMB 55 CardioComm Solutions Inc. 55 Immunogenicity 55 Well Tolerated 55 ChondroGene 55 RDWR 54 Child Adolesc Psychiatry 54 Candesartan 54 Free Full Text 54 Pivotal Trial 54 MERLIN TIMI 54 Arch Intern Med 54 Diabetic Macular Edema 54 Single Dose 54 #.#X ABOVE AVERAGE VOLUME 54 Panoro Minerals Ltd. 54 Molecular Cancer 54 Pirfenidone 54 PCI Biotech 54 Carpathian Gold 54 Oral Presentation 54 Ticagrelor 54 J Am Coll 54 Denufosol

Back to home page